Skip to main content
Premium Trial:

Request an Annual Quote

David Fenstermacher

DNAnexus has hired David Fenstermacher as VP of precision medicine and data services. Fenstermacher will supervise the vendor's data management products for precision health and drug discovery applications. Fenstermacher, a molecular biologist and informatician, previously served as VP of R&D bioinformatics at MedImmune. He also had been chief research information officer at Virginia Commonwealth University and was the founding chair of the Department of Biomedical Informatics at the H. Lee Moffitt Cancer Center.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.